Gladstone NOW: The Campaign Join Us on the Journey✕
With an estimated 44 million diagnosed with Alzheimer’s disease worldwide, research is moving quickly to better understand the disease.
In this webinar, hear a caregiver explain the steps she took to support her dad after he was diagnosed with Alzheimer’s disease, gain insights into why it has been so hard to come up with better treatments for this challenging condition, and learn about ongoing efforts to develop novel therapeutic strategies to halt and prevent Alzheimer’s disease, as well as other forms of dementia.
This event was hosted with Kensington Place, a memory care residence that exclusively serves individuals with memory loss and their families.
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
For Cancer Immunotherapy Month, Karin Pelka answers questions about how immunotherapy can treat patients with solid tumors and the challenges that scientists are working to overcome.
Gladstone Experts Cancer Genomic Immunology Data Science and Biotechnology Pelka LabDiscover how Gladstone fosters an environment in which people are having fun, working hard, and driven to save human lives.
Gladstone Experts Graduate Students and Postdocs Institutional NewsBruce Conklin and his team at Gladstone are tackling Charcot-Marie-Tooth (CMT) disease, the most common inherited neurological disorders—for which there is currently no cure.
Gladstone Experts Conklin Lab CRISPR/Gene Editing